Development of an End-user Informed Tenofovir Alafenamide (TAF) Implant for Long-acting (LA)-HIV Pre-exposure Prophylaxis (PrEP)

Gatto, G. J., Brand, R. M., Girouard, N., Li, L. A., Johnson, L., Marzinke, M. A., Krogstad, E., Siegel, A., Helms, E., Demkovich, Z., Luecke, E., & van der Straten, A. (2018). Development of an End-user Informed Tenofovir Alafenamide (TAF) Implant for Long-acting (LA)-HIV Pre-exposure Prophylaxis (PrEP). AIDS Research and Human Retroviruses, 34, 70.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

OCCASIONAL PAPER

Bringing an equity-centered framework to research
OCCASIONAL PAPER

The Preschool Entitlement
OCCASIONAL PAPER

Culturally informed community engagement
Article

Far-right and Jihadi terrorism within the United States